• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昼夜节律钟基因表达与胶质瘤肿瘤微环境及患者生存的关联

Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival.

作者信息

De La Cruz Minyety Julianie, Shuboni-Mulligan Dorela D, Briceno Nicole, Young Demarrius, Gilbert Mark R, Celiku Orieta, Armstrong Terri S

机构信息

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.

出版信息

Cancers (Basel). 2021 Jun 2;13(11):2756. doi: 10.3390/cancers13112756.

DOI:10.3390/cancers13112756
PMID:34199348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8199552/
Abstract

Circadian clock genes have been linked to clinical outcomes in cancer, including gliomas. However, these studies have not accounted for established markers that predict the prognosis, including mutations in Isocitrate Dehydrogenase (), which characterize the majority of lower-grade gliomas and secondary high-grade gliomas. To demonstrate the connection between circadian clock genes and glioma outcomes while accounting for the mutational status, we analyzed multiple publicly available gene expression datasets. The unsupervised clustering of 13 clock gene transcriptomic signatures from The Cancer Genome Atlas showed distinct molecular subtypes representing different disease states and showed the differential prognosis of these groups by a Kaplan-Meier analysis. Further analyses of these groups showed that a low period () gene expression was associated with the negative prognosis and enrichment of the immune signaling pathways. These findings prompted the exploration of the relationship between the microenvironment and clock genes in additional datasets. Circadian clock gene expression was found to be differentially expressed across the anatomical tumor location and cell type. Thus, the circadian clock expression is a potential predictive biomarker in glioma, and further mechanistic studies to elucidate the connections between the circadian clock and microenvironment are warranted.

摘要

昼夜节律时钟基因已与包括胶质瘤在内的癌症临床结局相关联。然而,这些研究并未考虑那些预测预后的既定标志物,包括异柠檬酸脱氢酶(IDH)的突变,该突变是大多数低级别胶质瘤和继发性高级别胶质瘤的特征。为了在考虑IDH突变状态的同时证明昼夜节律时钟基因与胶质瘤结局之间的联系,我们分析了多个公开可用的基因表达数据集。来自癌症基因组图谱的13个时钟基因转录组特征的无监督聚类显示出代表不同疾病状态的不同分子亚型,并通过Kaplan-Meier分析显示了这些组的不同预后。对这些组的进一步分析表明,低周期(Per)基因表达与不良预后和免疫信号通路的富集相关。这些发现促使我们在其他数据集中探索微环境与时钟基因之间的关系。发现昼夜节律时钟基因表达在解剖学肿瘤位置和细胞类型之间存在差异表达。因此,昼夜节律时钟表达是胶质瘤中一种潜在的预测生物标志物,有必要进行进一步的机制研究以阐明昼夜节律时钟与微环境之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/e11379dc9ae1/cancers-13-02756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/6c4983359cec/cancers-13-02756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/60a0bde11aab/cancers-13-02756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/34007cc0e03e/cancers-13-02756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/f534f2fd906c/cancers-13-02756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/e11379dc9ae1/cancers-13-02756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/6c4983359cec/cancers-13-02756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/60a0bde11aab/cancers-13-02756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/34007cc0e03e/cancers-13-02756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/f534f2fd906c/cancers-13-02756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/8199552/e11379dc9ae1/cancers-13-02756-g005.jpg

相似文献

1
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival.昼夜节律钟基因表达与胶质瘤肿瘤微环境及患者生存的关联
Cancers (Basel). 2021 Jun 2;13(11):2756. doi: 10.3390/cancers13112756.
2
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.在 IDH 突变型和 IDH 野生型弥漫性胶质瘤中,使用端粒酶启动子突变来标记具有相互临床行为的特定分子亚群。
J Neurosurg. 2018 Apr;128(4):1102-1114. doi: 10.3171/2016.11.JNS16973. Epub 2017 Jun 16.
3
The analysis of deregulated expression and methylation of the PER2 genes in gliomas.胶质瘤中PER2基因表达失调与甲基化的分析。
J Cancer Res Ther. 2014 Jul-Sep;10(3):636-40. doi: 10.4103/0973-1482.138202.
4
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.SHOX2是预测世界卫生组织II-III级弥漫性胶质瘤患者生存的有效独立生物标志物。
EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.
5
MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.磁共振成像特征和 IDH 基因突变状态在二级弥漫性胶质瘤中的作用:对诊断和预后的影响。
AJR Am J Roentgenol. 2018 Mar;210(3):621-628. doi: 10.2214/AJR.17.18457. Epub 2017 Dec 20.
6
Deregulated expression of the Per1 and Per2 in human gliomas.人类神经胶质瘤中 Per1 和 Per2 的表达失调。
Can J Neurol Sci. 2010 May;37(3):365-70. doi: 10.1017/s031716710001026x.
7
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.PI3 激酶突变和突变负荷作为弥漫性神经胶质瘤患者的不良预后标志物。
Acta Neuropathol Commun. 2015 Dec 23;3:88. doi: 10.1186/s40478-015-0265-4.
8
A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.核转运相关基因特征与 IDH 突变和 1p/19q 联合缺失可更好地预测胶质瘤患者的预后。
BMC Cancer. 2020 Nov 9;20(1):1072. doi: 10.1186/s12885-020-07552-3.
9
Comprehensive analysis of distinct circadian clock subtypes of adult diffuse glioma and their associations with clinicopathological, genetic, and epigenetic profiles.全面分析成人弥漫性神经胶质瘤不同的昼夜节律时钟亚型及其与临床病理、遗传和表观遗传特征的关联。
J Neuropathol Exp Neurol. 2024 Sep 1;83(9):736-744. doi: 10.1093/jnen/nlae055.
10
Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.生物钟时机失调:昼夜节律钟与低氧信号通路在多种恶性肿瘤中具有独特的肿瘤抑制和致癌作用及其相互作用。
J Transl Med. 2019 Apr 23;17(1):132. doi: 10.1186/s12967-019-1880-9.

引用本文的文献

1
Unravelling the link between circadian clock genes and brain tumors: From pathological disruptions to potential therapeutic interventions.揭示昼夜节律时钟基因与脑肿瘤之间的联系:从病理紊乱到潜在的治疗干预
Front Pharmacol. 2025 May 27;16:1617713. doi: 10.3389/fphar.2025.1617713. eCollection 2025.
2
Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learning.用于预测耐药性的胶质瘤中昼夜节律相关基因特征:整合转录组学和机器学习的综合分析
Discov Oncol. 2025 Feb 5;16(1):119. doi: 10.1007/s12672-025-01863-2.
3
Epigenetic clocks and gliomas: unveiling the molecular interactions between aging and tumor development.

本文引用的文献

1
Impact of age on the circadian visual system and the sleep-wake cycle in mus musculus.年龄对小家鼠昼夜视觉系统及睡眠-觉醒周期的影响。
NPJ Aging Mech Dis. 2021 May 4;7(1):10. doi: 10.1038/s41514-021-00063-w.
2
A circadian clock regulates efflux by the blood-brain barrier in mice and human cells.昼夜节律钟调节小鼠和人细胞的血脑屏障外排。
Nat Commun. 2021 Jan 27;12(1):617. doi: 10.1038/s41467-020-20795-9.
3
Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation.昼夜节律紊乱促进肿瘤免疫微环境重塑,有利于肿瘤细胞增殖。
表观遗传时钟与神经胶质瘤:揭示衰老与肿瘤发生之间的分子相互作用
Front Mol Biosci. 2024 Jul 26;11:1446428. doi: 10.3389/fmolb.2024.1446428. eCollection 2024.
4
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock.胶质母细胞瘤中肿瘤发生的分子机制:生物钟的新作用
NPJ Precis Oncol. 2024 Feb 20;8(1):40. doi: 10.1038/s41698-024-00530-z.
5
Clock gene Per2 modulates epidermal tissue repair in vivo.生物钟基因Per2在体内调节表皮组织修复。
J Cell Biochem. 2024 Feb;125(2):e30513. doi: 10.1002/jcb.30513. Epub 2024 Jan 16.
6
Review: therapeutic approaches for circadian modulation of the glioma microenvironment.综述:胶质瘤微环境昼夜节律调节的治疗方法
Front Oncol. 2023 Dec 20;13:1295030. doi: 10.3389/fonc.2023.1295030. eCollection 2023.
7
Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma.生物钟调控因子介导的分子亚型描绘了头颈部鳞状细胞癌肿瘤微环境的特征,并提示预后。
J Immunol Res. 2023 Jun 12;2023:9946911. doi: 10.1155/2023/9946911. eCollection 2023.
8
Watching the clock in glioblastoma.观察胶质母细胞瘤中的时钟。
Neuro Oncol. 2023 Nov 2;25(11):1932-1946. doi: 10.1093/neuonc/noad107.
9
CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients.CRS:一种用于预测癌症患者预后和治疗反应的生物钟节律评分模型。
J Transl Med. 2023 Mar 9;21(1):185. doi: 10.1186/s12967-023-04013-w.
10
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?胶质瘤发病相关常见基因概述及偏头痛作为危险因素的作用:预测性生物标志物还是治疗靶点?
J Pers Med. 2022 Nov 28;12(12):1969. doi: 10.3390/jpm12121969.
Sci Adv. 2020 Oct 14;6(42). doi: 10.1126/sciadv.aaz4530. Print 2020 Oct.
4
Single-cell transcriptomics allows novel insights into aging and circadian processes.单细胞转录组学为衰老和昼夜节律过程提供了新的见解。
Brief Funct Genomics. 2020 Dec 4;19(5-6):343-349. doi: 10.1093/bfgp/elaa014.
5
Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice.慢性昼夜节律紊乱调节乳腺癌干性和免疫微环境,从而促进小鼠转移。
Nat Commun. 2020 Jun 24;11(1):3193. doi: 10.1038/s41467-020-16890-6.
6
Immune suppression in gliomas.胶质瘤的免疫抑制。
J Neurooncol. 2021 Jan;151(1):3-12. doi: 10.1007/s11060-020-03483-y. Epub 2020 Jun 15.
7
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.脑肿瘤微环境景观的剖析揭示了免疫细胞的疾病特异性改变。
Cell. 2020 Jun 25;181(7):1643-1660.e17. doi: 10.1016/j.cell.2020.05.007. Epub 2020 May 28.
8
Noise-driven cellular heterogeneity in circadian periodicity.噪声驱动的生物钟周期性细胞异质性。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10350-10356. doi: 10.1073/pnas.1922388117. Epub 2020 May 1.
9
Chronic circadian misalignment accelerates immune senescence and abbreviates lifespan in mice.慢性昼夜节律失调加速了小鼠的免疫衰老并缩短了其寿命。
Sci Rep. 2020 Feb 13;10(1):2569. doi: 10.1038/s41598-020-59541-y.
10
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.了解胶质母细胞瘤的免疫微环境,为开发新的免疫治疗策略奠定基础。
Elife. 2020 Feb 4;9:e52176. doi: 10.7554/eLife.52176.